It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
During the United Kingdom’s Covid-19 vaccination campaign, general practitioners (GPs) have held responsibility for vaccinating housebound patients. This presented them with a large, complex and unfamiliar logistical challenge, namely determining the most time-efficient route to visit multiple patients at their home address. In response to a lack of existing solutions tailored specifically to vaccination, and in light of overwhelming demand, Vaximap (https://www.vaximap.org) was created in January 2021 to automate the process of route planning. It is free of charge for all users and has been used to-date to plan vaccinations for over 470,000 patients. This article analyses usage data to estimate the time savings (3 work years) and financial savings (£110,000) the service has yielded for GP surgeries, thus demonstrating that it helped to accelerate the UK’s Covid-19 vaccination campaign at critical moments.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details



1 Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, England (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); Sir Peter Mansfield Imaging Centre, School of Medicine, University of Nottingham, Nottingham, England (GRID:grid.4563.4) (ISNI:0000 0004 1936 8868)
2 Squarepoint Capital LLP, London, England (GRID:grid.4563.4)
3 Visa Inc., London, England (GRID:grid.474754.1)
4 Institute of Biomedical Engineering, Department of Engineering Science, University of Oxford, Oxford, England (GRID:grid.4991.5) (ISNI:0000 0004 1936 8948); Defence Deanery, Academic Department of Military Surgery and Trauma, Birmingham, England (GRID:grid.4991.5)